Rejon-Parrilla J, Espin J, Garner S, Kniazkov S, Epstein D
Front Pharmacol. 2023; 14:1199500.
PMID: 38089054
PMC: 10715052.
DOI: 10.3389/fphar.2023.1199500.
Elsallab M, Maus M
Nat Biotechnol. 2023; 41(12):1698-1708.
PMID: 37884746
DOI: 10.1038/s41587-023-01981-8.
Torrents S, Grau-Vorster M, Vives J
Adv Exp Med Biol. 2023; 1420:139-149.
PMID: 37258788
DOI: 10.1007/978-3-031-30040-0_9.
Cuende N, Vilarrodona A, Vuelta E, Marazuela R, Herrera C, Querol S
Transplantation. 2023; 107(4):867-877.
PMID: 36721301
PMC: 10065823.
DOI: 10.1097/TP.0000000000004527.
Ruiz-Lopez J, Cardona J, Garzon I, Perez M, Alaminos M, Chato-Astrain J
Biomedicines. 2022; 10(7).
PMID: 35884945
PMC: 9313464.
DOI: 10.3390/biomedicines10071640.
Compliance in Non-Clinical Development of Cell-, Gene-, and Tissue-Based Medicines: Good Practice for Better Therapies.
Lopez-Navas L, Torrents S, Sanchez-Pernaute R, Vives J
Stem Cells Transl Med. 2022; 11(8):805-813.
PMID: 35830540
PMC: 9397649.
DOI: 10.1093/stcltm/szac046.
Perspectives, Expectations, and Concerns of European Patient Advocates on Advanced Therapy Medicinal Products.
Benvenuti S, Wang C, Borroni S
Front Med (Lausanne). 2021; 8:728529.
PMID: 34888320
PMC: 8649896.
DOI: 10.3389/fmed.2021.728529.
3D bioprinting for orthopaedic applications: Current advances, challenges and regulatory considerations.
Stanco D, Urban P, Tirendi S, Ciardelli G, Barrero J
Bioprinting. 2021; 20:None.
PMID: 34853818
PMC: 8609155.
DOI: 10.1016/j.bprint.2020.e00103.
Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine.
Laurent A, Scaletta C, Abdel-Sayed P, Michetti M, Flahaut M, Simon J
Biomedicines. 2021; 9(8).
PMID: 34440276
PMC: 8394413.
DOI: 10.3390/biomedicines9081072.
Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues.
Hug K
J Parkinsons Dis. 2021; 11(s2):S147-S155.
PMID: 34092655
PMC: 8543290.
DOI: 10.3233/JPD-212639.
Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
Chemali M, Laurent A, Scaletta C, Waselle L, Simon J, Michetti M
J Burn Care Res. 2021; 42(5):911-924.
PMID: 33970273
PMC: 8483250.
DOI: 10.1093/jbcr/irab080.
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.
Al-Dourobi K, Laurent A, Deghayli L, Flahaut M, Abdel-Sayed P, Scaletta C
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33671009
PMC: 7997469.
DOI: 10.3390/ph14030201.
Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology.
Laurent A, Hirt-Burri N, Scaletta C, Michetti M, de Buys Roessingh A, Raffoul W
Front Bioeng Biotechnol. 2020; 8:557758.
PMID: 33195124
PMC: 7644790.
DOI: 10.3389/fbioe.2020.557758.
Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.
Azuma K, Yamanaka S
Regen Ther. 2019; 4:36-47.
PMID: 31245486
PMC: 6581825.
DOI: 10.1016/j.reth.2016.01.009.
Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?.
Roura S, Galvez-Monton C, Mirabel C, Vives J, Bayes-Genis A
Stem Cell Res Ther. 2017; 8(1):238.
PMID: 29078809
PMC: 5658929.
DOI: 10.1186/s13287-017-0695-y.
Accelerating Patients' Access to Advanced Therapies in the EU.
Elsanhoury A, Sanzenbacher R, Reinke P, Abou-El-Enein M
Mol Ther Methods Clin Dev. 2017; 7:15-19.
PMID: 28971109
PMC: 5609878.
DOI: 10.1016/j.omtm.2017.08.005.
Burn patient care lost in good manufacturing practices?.
Dimitropoulos G, Jafari P, de Buys Roessingh A, Hirt-Burri N, Raffoul W, Applegate L
Ann Burns Fire Disasters. 2017; 29(2):111-115.
PMID: 28149232
PMC: 5286987.
